U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07888075) titled 'OLE Study Subsequent to Parent Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLC' on Oct. 15.
Brief Summary: The purpose of the OLE study is to evaluate the long-term safety and tolerability of rilogrotug treatment in participants who have completed the parent study and are eligible to receive continued treatment.
Study Start Date: Feb., 2027
Study Type: INTERVENTIONAL
Condition:
Cachexia; Cancer
Cachexia
Cachexia-Anorexia Syndrome
Metastatic Colorectal Cancer (CRC)
Metastatic Non-small Cell Lung Cancer (NSCLC)
Weight Loss
Anorexia
Intervention:
BIOLOGICAL: Ri...